Surgery, Gastroenterology and Oncology
Vol. 23, No. 3, Jun 2018
Endoscopic Mucosal Resection Using Band Ligation (EBL) Will Serve Two Ends in the Treatment for Small Rectal Neuroendocrine Tumors? A Multicenter Retrospective Study
Il Hyun Baek, Young Kwan Jo, Seong Hwan Kim, Kwang Ro Joo
ORIGINAL PAPER, Jun 2018
Article DOI: 10.21614/sgo-23-3-166
Background: Rectal neuroendocrine tumor (NET)s that are <10mm in diameter can be treated with local excision including endoscopic resection. Endoscopic mucosal resection (EMR) of rectal NETis often associated with involvement of the resection margin. Endoscopic submucosal dissection (ESD) has more histologically complete resection. However, ESD can lead to more serious complications and longer procedure time than EMR.
Endoscopic mucosal resection using band ligation (EBL) is a new technique for eliminating the rectal NET. The aim of the this study is to evaluate the therapeutic efficacy and convenience of EBL with that of EMR or ESD for the endoscopic therapy of rectal NET.

Methods: From March 2013 to February 2018, we enrolled consecutive patients with rectal NETs less than 15mm in diameter and without lymph node enlargement. The histologic complete resection rate, length of procedures, and post-procedure complications were retrospectively analyzed.

Results: Twelve NETs were excised by EBL, and 43 lesions were removed by EMR and 20 lesions were resected using ESD.The histologic complete resection rate was 66.7% in the EBL group, 74.4% in the EMR group, and 90.0% in the ESD group (P=0.249)). The tumor-free deep and lateral resection margins of EBL group were greater than in the EMR group (P< 0.001 and P = 0.093, respectively). There was no perforation in any group.Post-procedure bleeding occurred in three cases of EBL and was controlled endoscopically. Additionaly, the mean procedure time was significantly longer in ESDthan EBL (p<0.001).
During the follow-up period, two local recurrence and two distant metastasis were detected in the EMR group only.

Conclusions: Compared to EMR, EBL showedsimilar procedure time and complication rate, lower recurrence rate, lower lymphatic invasion, and deeper tumor free resection margin. EBL is technically easy to perform and can be safely performed in less time than ESD.EBL enables deep vertical resection margins and high complete resection ratecomparable to ESD. Considering the benefits of ease, efficiency, and short procedure time, EBL could be considered either an alternative to ESDor an optional therapy for small rectal NET.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 4071


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Dec 2025

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/
Publisher’s Note:
The opinions, statements, and data contained in article are solely those of the authors and not of Surgery, Gastroenterology and Oncology journal or the editors. Publisher and the editors disclaim responsibility for any damage resulting from any ideas, instructions, methods, or products referred to in the content.